Australia markets closed

BioPharma Credit PLC (B3P.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
0.79000.0000 (0.00%)
As of 08:06AM CEST. Market open.
Currency in EUR

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.22
52-week change 31.28%
S&P500 52-week change 321.23%
52-week high 30.8000
52-week low 30.7750
50-day moving average 30.7868
200-day moving average 30.7868

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 5N/A
Implied shares outstanding 6N/A
Float 81.07B
% held by insiders 16.26%
% held by institutions 141.13%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 79.90%
Operating margin (ttm)65.59%

Management effectiveness

Return on assets (ttm)4.98%
Return on equity (ttm)8.10%

Income statement

Revenue (ttm)135.74M
Revenue per share (ttm)0.10
Quarterly revenue growth (yoy)-59.80%
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)108.45M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)-67.10%

Balance sheet

Total cash (mrq)135.05M
Total cash per share (mrq)0.11
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)9.79
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)123.18M
Levered free cash flow (ttm)56.88M